Medical Condition News

RSS

Researchers discover mechanism behind skin inflammation in eczema

Publishing online this week in Cell Host & Microbe, researchers at Johns Hopkins report the discovery of a key underlying immune mechanism that explains why to how our skin becomes inflamed from conditions such as atopic dermatitis, more commonly known as eczema. Toxin-producing bacteria on the surface of our skin induces a protein that causes our own cells to react and cause inflammation.

8 Nov 2017

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

Researchers investigating ways to deliver high doses of cancer-killing drugs inside tumors have shown they can use a laser and light-activated gold nanoparticles to remotely trigger the release of approved cancer drugs inside cancer cells in laboratory cultures.

8 Nov 2017

UA Cancer Center researchers delve deeper into benefits and harms of selenium supplementation

Personalized medicine -- health care tailored to the individual patient -- not only involves the use of prescription medications but vitamins and supplements as well.

8 Nov 2017

New inpatient program can be powerful tool to close gap in addiction treatment

A new program at Boston Medical Center's Grayken Center for Addiction is showing that connecting patients to addiction treatment when they are hospitalized for other conditions can be a powerful tool in closing a gap in addiction treatment.

8 Nov 2017

Chronic liver inflammation promotes cancer by suppressing immunosurveillance, study finds

Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that's because inflammation directly affects cancer cells, stimulating their division and protecting them from cell death.

8 Nov 2017

Research: Prognosis for people with diabetic foot ulcers worse than previously thought

The prognosis for people with an infected diabetic foot ulcer is worse than was previously thought, according to new research.

8 Nov 2017

Novel approach could help predict how well patients respond to cancer treatment

A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.

8 Nov 2017

Early intervention may be crucial to successful treatment of Friedreich's ataxia

New research published today in Disease Models & Mechanisms indicates that early intervention should be a key target in the development of new therapeutics for Friedreich's ataxia, as current treatments may be administered too late to target the disease effectively.

8 Nov 2017

Research suggests possibility of preventing and treating Parkinson's disease using licorice extract

DGIST's research team led by Dr. Yun-Il Lee in Well-Aging Research Center has identified a new mechanism of inhibition of dopaminergic neuronal apoptosis and suggested the possibility of preventing and treating Parkinson's disease.

8 Nov 2017

Lavender aromatherapy reduces preoperative anxiety in surgery patients, study finds

Lavender aromatherapy reduced preoperative anxiety in a study of ambulatory surgery patients undergoing procedures in general otolaryngology. The effect observed in the Laryngoscope Investigative Otolaryngology study was modest, however.

8 Nov 2017

California cracks down on weed killer as lawsuits abound

Jack McCall was a fixture at the local farmers market, where he sold avocados and other fruits he grew on his 20-acre ranch in Cambria, on California's Central Coast.

8 Nov 2017

Scientists find way to stimulate growth of new neural connections in the brain

A team led by University of Idaho scientists has found a way to stimulate formation of new neural connections in the adult brain in a study that could eventually help humans fend off memory loss, brain trauma and other ailments in the central nervous system.

8 Nov 2017

New ‘SMART’ system holds potential to accelerate molecular structure identification process

An interdisciplinary team of researchers at the University of California San Diego has developed a method to identify the molecular structures of natural products that is significantly faster and more accurate than existing methods.

8 Nov 2017

Certain factors associated with sleep disturbance in type 2 diabetes patients

In a Journal of Advanced Nursing study of 90 adults with type 2 diabetes, female gender, elevated blood sugar levels, neuropathic pain, and fatigue were related to sleep disturbance, even after controlling for factors such as age, diabetes duration, depressive symptoms, and distress.

8 Nov 2017

Adipocytes may reduce effectiveness of chemotherapeutic drug

Adipocytes, or fat cells, can absorb and metabolize the chemotherapeutic agent daunorubicin, reducing the effectiveness of the drug and potentially contributing to poorer treatment outcomes.

8 Nov 2017

Study finds link between lupus and elevated risk of dementia

A new International Journal of Geriatric Psychiatry study indicates that the risk of dementia may be elevated in individuals with systemic lupus erythematosus (SLE), an autoimmune disease affecting a range of systems including the peripheral and central nervous system.

8 Nov 2017

Overabundance of gut bacteria may exacerbate pain in patients with sickle cell disease

An overabundance of the bacteria Veillonella in the digestive tract may increase pain in patients with sickle cell disease (SCD).

8 Nov 2017

New discovery in beta-cell pathway shows potential to improve effectiveness of diabetes drugs

Over the past 15 years, University of Alabama at Birmingham endocrinologist Anath Shalev, M.D., has unraveled a crucial biological pathway that malfunctions in diabetes.

8 Nov 2017

New program targets cancers affecting the liver and bile ducts

Cancers affecting the liver and bile ducts will be the target of a new program at Perlmutter Cancer Center at NYU Langone Health to provide multidisciplinary clinical care and rapidly bring important new research to the clinic.

7 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

Medical Condition News

Researchers discover mechanism behind skin inflammation in eczema

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

UA Cancer Center researchers delve deeper into benefits and harms of selenium supplementation

New inpatient program can be powerful tool to close gap in addiction treatment

Chronic liver inflammation promotes cancer by suppressing immunosurveillance, study finds

Research: Prognosis for people with diabetic foot ulcers worse than previously thought

Novel approach could help predict how well patients respond to cancer treatment

Early intervention may be crucial to successful treatment of Friedreich's ataxia

Research suggests possibility of preventing and treating Parkinson's disease using licorice extract

Lavender aromatherapy reduces preoperative anxiety in surgery patients, study finds

California cracks down on weed killer as lawsuits abound

Scientists find way to stimulate growth of new neural connections in the brain

New ‘SMART’ system holds potential to accelerate molecular structure identification process

Certain factors associated with sleep disturbance in type 2 diabetes patients

Adipocytes may reduce effectiveness of chemotherapeutic drug

Study finds link between lupus and elevated risk of dementia

Overabundance of gut bacteria may exacerbate pain in patients with sickle cell disease

New discovery in beta-cell pathway shows potential to improve effectiveness of diabetes drugs

New program targets cancers affecting the liver and bile ducts

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News